Skip to main content
Atrás
MOH logo

Molina Healthcare, Inc.

Calidad de datos: 100%
MOH
NYSE Healthcare Medical - Healthcare Plans
$141.74
▲ $6.50 (4.81%)
Cap. Mercado: 7.30B
Rango del Día
$132.88 $142.11
Rango de 52 Semanas
$121.06 $359.97
Volumen
1,497,320
Promedio 50D / 200D
$160.65 / $181.77
Cierre Anterior
$135.24

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (627 pares)

Métrica Acción Mediana del Sector
P/E 15.5 0.4
P/B 1.8 2.9
ROE % 11.0 3.9
Net Margin % 1.0 3.8
Rev Growth 5Y % 13.1 10.0
D/E 1.0 0.2

Precio Objetivo de Analistas

Hold
$175.64 +23.9%
Low: $124.00 High: $310.00
P/E Futuro
26.8
EPS Futuro
$5.04
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
45 B

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2030 $25.38
$23.65 – $27.55
 53 B 2
FY2029 $19.10
$17.80 – $20.73
 50 B 2
FY2028 $12.34
$10.37 – $13.34
 49 B 4

Puntos Clave

Revenue grew 13.09% annually over 5 years — strong growth
Earnings declined -59.97% over the past year
ROE of 11.02% — decent returns on equity
Negative free cash flow of -636.00M
Capital efficient — spends only 0.22% of revenue on capex

Crecimiento

Revenue Growth (5Y)
13.09%
Revenue (1Y)11.75%
Earnings (1Y)-59.97%
FCF Growth (3Y)N/A

Calidad

Return on Equity
11.02%
ROIC7.30%
Net Margin1.04%
Op. Margin1.72%

Seguridad

Debt / Equity
0.97
Current Ratio1.69
Interest Coverage4.07

Valoración

P/E Ratio
15.47
P/B Ratio1.79
EV/EBITDA8.96
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 11.75% Revenue Growth (3Y) 15.47%
Earnings Growth (1Y) -59.97% Earnings Growth (3Y) -34.23%
Revenue Growth (5Y) 13.09% Earnings Growth (5Y) -8.01%
Profitability
Revenue (TTM) 45.43B Net Income (TTM) 472.00M
ROE 11.02% ROA 3.03%
Gross Margin 8.97% Operating Margin 1.72%
Net Margin 1.04% Free Cash Flow (TTM) -636.00M
ROIC 7.30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.97 Current Ratio 1.69
Interest Coverage 4.07 Dividend Yield 0.00%
Valuation
P/E Ratio 15.47 P/B Ratio 1.79
P/S Ratio 0.16 PEG Ratio -0.33
EV/EBITDA 8.96 Dividend Yield 0.00%
Market Cap 7.30B Enterprise Value 7.00B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 45.43B 40.65B 34.07B 31.97B 27.77B
Net Income 472.00M 1.18B 1.09B 792.00M 659.00M
EPS (Diluted) 8.92 20.42 18.78 13.54 11.25
Gross Profit 4.08B 4.74B 4.33B 3.93B 3.28B
Operating Income 781.00M 1.71B 1.57B 1.17B 1.02B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 15.56B 15.63B 14.89B 12.31B 12.21B
Total Liabilities 11.50B 11.13B 10.68B 9.35B 9.58B
Shareholders' Equity 4.07B 4.50B 4.22B 2.96B 2.63B
Total Debt 3.95B 3.12B 2.39B 2.39B 2.39B
Cash & Equivalents 4.25B 4.66B 4.85B 4.01B 4.44B
Current Assets 12.44B 12.77B 12.54B 10.08B 10.06B
Current Liabilities 7.37B 7.90B 8.17B 6.86B 7.05B

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#382 of 618
28

Actividad Reciente

Entró Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026